Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Inova Health Care Services
National Cancer Institute (NCI)
Taproot Health
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Mayo Clinic
Technische Universität Dresden
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Illinois at Chicago
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of California, San Francisco
Children's Oncology Group
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute